Modeling mtDNA hypermethylation vicious circle mediating Aβ-induced endothelial damage memory in HCMEC/D3 cell
Related Experiment Video
Updated: Dec 7, 2025

An Alternative Culture Method to Maintain Genomic Hypomethylation of Mouse Embryonic Stem Cells Using MEK Inhibitor PD0325901 and Vitamin C
Published on: June 1, 2018
HaoChen Liu1, Hong Zhang1, Yixuan Zhang1
1Center of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China.
Abstract:
It is well accepted that accumulation of beta-amyloid (Aβ) may involve in endothelial dysfunction during the Alzheimer's disease (AD) progression. However, cerebrovascular function cannot be improved by removing Aβ in AD animal models. The reasons for these paradoxical results still remain to be further investigated. We hypothesize that Aβ exposure may cause persistence damage to cerebral endothelial cell even after Aβ is removed (termed as cerebrovascular endothelial damage memory) mitochondria DNA (mtDNA) hypermethylation is assumed to be involved in this process. The aim of this study is to investigate whether Aβ exposure induces cerebrovascular endothelial damage memory in endothelial cells and mtDNA hypermethylation involves in this process. The hCMEC/D3 cell is treated with Aβ1-42 for 12h and then withdraw Aβ1-42 for another 12h incubation to investigate whether cerebrovascular endothelial damage memory exists in endothelial cells. The levels of mtDNA methylation and cell vitality were not improved by removing Aβ1-42 after 12h Aβ1-42 incubation which suggested that the cerebrovascular endothelial damage memory may exist in endothelial cells. Kinetics model analysis suggested that mtDNA hypermethylation involves in initiating the cerebrovascular endothelial damage memory otherwise α-oxoglutarate (AKG) exhaustion plays a vital role in maintaining this process. DNA methylation inhibitor decitabine and AKG supplement may relieve the cerebrovascular endothelial damage memory dose dependently. This study provides a novel feature of cerebrovascular endothelial damage induced by Aβ.
Insights
Alzheimer's disease beta-amyloid (Aβ) causes lasting brain endothelial cell damage, a memory effect. This damage persists even after Aβ removal, linked to mitochondrial DNA hypermethylation.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Beta-amyloid (Aβ) accumulation is linked to endothelial dysfunction in Alzheimer's disease (AD).
- Removing Aβ in AD models does not always restore cerebrovascular function, suggesting persistent damage.
- The mechanisms behind this persistent damage, termed cerebrovascular endothelial damage memory, are not fully understood.
Purpose of the Study:
- To investigate if Aβ exposure induces cerebrovascular endothelial damage memory in endothelial cells.
- To determine the role of mitochondrial DNA (mtDNA) hypermethylation in this memory effect.
- To explore potential therapeutic interventions targeting this damage memory.
Main Methods:
- Human cerebral microvascular endothelial cells (hCMEC/D3) were exposed to Aβ(1-42) for 12 hours, followed by a 12-hour withdrawal period.
- Cell vitality and mtDNA methylation levels were assessed after Aβ removal.
- Kinetics modeling was used to analyze the involvement of mtDNA hypermethylation and α-oxoglutarate (AKG) in damage memory.
- The effects of a DNA methylation inhibitor (decitabine) and AKG supplementation were evaluated.
Main Results:
- Endothelial cell vitality and mtDNA methylation levels did not recover after Aβ removal, indicating the presence of cerebrovascular endothelial damage memory.
- Kinetics analysis suggested mtDNA hypermethylation initiates the damage memory, while AKG exhaustion maintains it.
- Decitabine and AKG supplementation dose-dependently ameliorated the Aβ-induced cerebrovascular endothelial damage memory.
Conclusions:
- Aβ exposure induces a persistent cerebrovascular endothelial damage memory in endothelial cells.
- mtDNA hypermethylation plays a key role in initiating this damage memory.
- AKG exhaustion is crucial for maintaining the damage memory, which can be potentially reversed by decitabine and AKG supplementation.
More Related Videos
06:52Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
Published on: July 6, 2019
06:41Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025